The effectiveness of moxifloxacin in the treatment of community-acquired pneumonia
The article presents the results of domestic and international studies of the use of the fourth-generation fluoroquinolone moxifloxacin in the treatment of commu-nity-acquired pneumonia and pneumonia caused by SARS-CoV-2. Analysis of the clinical use of moxifloxacin in the treatment of complication...
Guardado en:
Autores principales: | Dmytro Dmytriiev, Oleksandr Nazarchuk, Yuliana Babina |
---|---|
Formato: | article |
Lenguaje: | RU UK |
Publicado: |
Interdisciplinary Academy of Pain Medicine
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fad54fdfbf54f1ca15f44a7e80513d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SIMULTANEOUS QUANTITATION OF MOXIFLOXACIN AND STATINS INAPI BY RP-HPLC
por: Qamar,Fatima, et al.
Publicado: (2019) -
SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE SODIUM PHOSPHATE IN BULK AND IN OPHTHALMIC SOLUTION BY RP- HPLC
por: DHUMAL,D. M, et al.
Publicado: (2012) -
Management of Community acquired pneumonia in the Emergency Room
por: Eduardo Esteban-Zubero, et al.
Publicado: (2019) -
Features of Hematological and Hemostasiological Parameters in Coronavirus Infection COVID-19 and Community-Acquired Pneumonia
por: E. A. Borodulina, et al.
Publicado: (2021) -
INFLUENCE OF ULTRAVIOLET BLOOD IRRADIATION ON COVID-19 ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA
por: I. Khodza, et al.
Publicado: (2019)